Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
4
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Friedreich's Ataxia
View Full LandscapeNo patent data available. Pre-approval drugs may not have Orange Book listings.
Puldysa
Treatment of respiratory dysfunction in patients with Duchenne muscular dystrophy (DMD) not using glucocorticoids
Raxone
Raxone is indicated for the treatment of visual impairment in adolescent and adult patients with Leber’s Hereditary Optic Neuropathy (LHON).
View on EMA